. . . . . . . "[NSCLC cells expressed VEGFR-3 and EGFR.Vandetanib treatment of NSCLC cells resulted in inhibition of EGFR and VEGFR-3 and inhibition of ?-estradiol-induced P-MAPK activation, demonstrating that vandetanib blocks ?-estradiol-induced EGFR signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:12:48+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .